Tested Applications
Positive IHC detected in | human stomach tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Positive IF/ICC detected in | SW480 cells |
Recommended dilution
Application | Dilution |
---|---|
Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
24035-1-AP targets ANKRD22 in IHC, IF/ICC, ELISA applications and shows reactivity with human samples.
Tested Reactivity | human |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | ANKRD22 fusion protein Ag21248 Predict reactive species |
Full Name | ankyrin repeat domain 22 |
Calculated Molecular Weight | 191 aa, 22 kDa |
GenBank Accession Number | BC021671 |
Gene Symbol | ANKRD22 |
Gene ID (NCBI) | 118932 |
RRID | AB_3669429 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen Affinity purified |
UNIPROT ID | Q5VYY1 |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Ankyrin repeat domain-containing protein 22 (ANKRD22) is a novel N-myristoylated protein with a predicted single-pass transmembrane domain. ANKRD22 could potentially act as a novel therapeutic target for non-small cell lung cancer (NSCLC) (PMID: 28667340).
Protocols
Product Specific Protocols | |
---|---|
IHC protocol for ANKRD22 antibody 24035-1-AP | Download protocol |
IF protocol for ANKRD22 antibody 24035-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |